FarmavitaR+

1. Pricing and Reimbursement Strategies
(Reports/Market Report)

... the growth of innovative technologies such as molecular diagnostics. An OEM's pricing is fundamentally based on its desired Return-on-Investment and the overall cost of manufacturing its equipment. Fair ...

2. Pricing and Reimbursement Conference Review
(Pricing and Reimbursment/Pricing and Reimbursment)

... ruined only by a bad weather which did not allow a proper sightseeing of the city and disturbed air traffic which made problems to the return flight of most participants. It was evident from the ...

3. Drug repositioning
(Regulatory Affairs/Other issues)

... bang for its R&D buck by generating some return out of failed drug candidates and extra return out of others. Drug re-positioning has become a key strategy for pharmaceutical groups, and according ...

4. Optimizing Brand Lifecycle Management
(Reports/Market Report)

... brands are growing, product lifecycles are evolving for the worst. Effective lifecycle management is becoming a must for Pharma looking to maximize their return on investment, regardless of which stage ...

5. Pricing & Reimbursement
(Pricing and Reimbursment/Pricing and Reimbursment)

... even greater pressure on pharma companies. In addition to the credit crunch, ever fewer novel products are coming to market, contributing to the declining return on investment. It is now a perquisite ...

6. eHealth for the Pharmaceutical Industry
(Reports/Market Report)

... practice medicine more efficiently and effectively will attract return site users and foster brand loyalty. It is important to identify how often consumers access the Internet. Marketing initiatives ...

7. Benchmarking Patent Expiries
(Reports/Company Report)

Benchmarking Patent Expiries - Key Factors Affecting Brand Erosion at Patent Expiry With declining returns from drug development pipelines, preservation of branded revenues is key for manufacturers. ...

8. Market Trends
(Reports/Market Report)

... cost of developing novel products. With a decrease in R&D productivity in recent years, in order to maximize the return on investment, drugs launched in the US and 5EU markets between 2002 ...

9. Winning Product Launch Strategies
(Reports/Product Report)

Winning Product Launch Strategies: Maximizing sales from new pharmaceutical products With pharmaceutical R&D continuing to suffer from declining productivity levels and stagnant returns on investment, ...

10. Patent Protection Strategies
(Reports/Market Report)

... strategies, exploit legislation effectively and secure the lifecyles of your innovations to maximise revenue returns. Read more...  ...

11. The Future of Biosimilars
(Reports/Product Report)

... established regulatory framework in the EU have also contributed to industrial obtrusiveness, but for those developers who persevere, biosimilars are set to offer lucrative returns. The Future of Biosimilars: ...

12. Translational Medicine in Biopharmaceutical R&D
(Reports/Market Report)

... drug failures and low returns on investment, companies who are increasingly facing major patent expiries and scarcely populated late-stage pipelines have accelerated efforts to enhance the speed and efficiency ...

13. Strategic RA Consulting
(Regulatory Affairs/Regulatory Affairs News)

... market. On the other hand, it is also essential that marketing drives the choice of procedure — return on investment, the size and type of market, and long-term corporate strategy is crucial to the ...

14. Management Practice
(QA and GMP/GMP/GLP/GCP/GDP)

... information from a wide range of threats in order to ensure business continuity, minimize business risk, and maximize return on investments and business opportunities.Information security is achieved by ...

15. Interpharm Consultancy
(Partners/Consultants)

... up its UK business and then returned to consultancy work - see website at (http://www.interpharm-consultancy.co.uk/). Interpharm is therefore able to provide help and advice on the basis of extensive generic ...

16. Privacy Protection
(Uncategorised Content)

...  We use return email addresses to answer the email we receive. Such addresses are not used for any other purpose and are not shared with outside parties. You can register with our website if you would ...